Perrigo Company plc

NYSE:PRGO

Drug Manufacturers - Specialty & Generic

Healthcare
$16.94 -1.97%

-$0.20 today

Market cap
$2.35B
Beta
0.52
P/E (TTM)
-0.8
EPS (TTM)
-$13.10
Dividend yield
11.65%
52W Low $9.23High $28.44

Volume 2.57M

Average 2.96M

PRGO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Perrigo Company plcNYSE: PRGO

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin narrows to 30.7%

Gross margin was 30.7% in Q2 FY2026, down 3.7 pp from a year earlier. On a trailing-twelve-month basis it was 33.3%, down 2.5 pp year over year. Over 3 fiscal years it widened by 2.4 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
30.7%-2.9 pp QoQ
Last fiscal yearDec 2025
35.1%-0.1 pp YoY
LTMJun 2026
33.3%-2.5 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.7 pp——
1 year-0.1 pp——
3 years+2.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
35.1%
Year-over-year change
-0.1pp

Gross Margin vs competitors

How PRGO compares with its peers on the latest reported figures

  • PRGO's LTM Jun 2026 gross margin of 33.3% is the 6th highest of the 10 companies compared; the peer median is 65.3%.
  • Its year-over-year change of -2.5 pp is the 5th highest of 9, against a peer median of -1.7 pp.
  • Over three fiscal years its change of +2.4 pp compares with a peer median of +0.5 pp.
PRGO Competitors Peer median
Gross Margin for PRGO and competitors
Company Period LTM level YoY 3-year change
SUPNSupernus Pharmaceuticals, Inc.LTM Jun 202688.1% -0.5 pp+2.7 pp
HTFLHeartflow, Inc. Common StockLTM Sep 202681.8% +6.2 pp—
BHCBausch Health Companies Inc.LTM Jun 202671.8% +1.1 pp-0.3 pp
LIVNLivaNova PLCLTM Sep 202667.9% -0.6 pp-1.5 pp
ATECAlphatec Holdings, Inc.LTM Mar 202665.3% -3.6 pp+3.2 pp
PRGOPerrigo Company plcLTM Jun 202633.3% -2.5 pp+2.4 pp
SGRYSurgery Partners, Inc.LTM Sep 202621.1% -2.8 pp+0.5 pp
HCMHUTCHMED (China) LimitedLTM Jun 20258.9% -20.9 pp+11.6 pp
TARSTarsus Pharmaceuticals, Inc.LTM Sep 20260.5% -88.3 pp-3.1 pp
SRRKScholar Rock Holding CorporationLTM Sep 2026-8236.0% ——
Peer median (excluding PRGO) 65.3%-1.7 pp+0.5 pp

Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.14B4.45B4.66B4.37B4.25B
Cost of Revenue2.72B3B2.98B2.83B2.76B
Gross Profit1.42B1.46B1.68B1.54B1.49B
Gross Margin34.2%32.7%36.1%35.3%35.1%
Research & Development122M123.1M122.5M112.2M95.4M
Selling, General & Admin1.11B1.21B1.27B1.11B526.5M
Operating Expenses1.01B1.38B1.53B1.43B1.15B
Depreciation & Amortization312.2M338.6M359.5M325.9M337.5M
EBITDA695.9M355.5M525M433M(797.9M)
EBITDA Margin16.8%8.0%11.3%9.9%-18.8%
Operating Income410.4M78.9M151.9M112.9M343.3M
Operating Margin9.9%1.8%3.3%2.6%8.1%
Interest Income00000
Interest Expense125M156M173.8M187.8M162.5M
Other Income / Expenses(151.7M)(218M)(160.2M)(193.6M)(1.64B)
Income Before Tax258.7M(139.1M)(8.3M)(80.7M)(1.3B)
Pre-Tax Margin6.3%-3.1%-0.2%-1.8%-30.5%
Income Tax Expense389.6M(8.2M)(3.9M)80M104.4M
Net Income(68.9M)(140.6M)(12.7M)(171.8M)(1.43B)
Net Margin-1.7%-3.2%-0.3%-3.9%-33.5%
EPS (Basic)(0.98)(0.97)(0.09)(1.25)(10.29)
EPS (Diluted)(0.98)(0.97)(0.09)(1.25)(10.29)
Weighted Avg Shares133.6M134.5M135.3M137.4M138.5M
Weighted Avg Shares (Diluted)133.6M134.5M135.3M137.4M138.5M

Perrigo Company plc

NYSE:PRGO

Intrinsic Alpha fair value

Locked

Current Price

$16.94

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.